☆ 4.4 Letter

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)

Get Full Text
Add to Collection

Journal

CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 67, Issue 4, Pages 967-969

Publisher

SPRINGER
DOI: 10.1007/s00280-011-1582-3

Keywords

-

Categories

Oncology Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.